[1]董玉任,李拥军,罗松平,等.丹参多酚酸盐在急诊患者缺血性心肌损伤治疗中的应用[J].陕西中医,2019,(7):871-874.
　DONG Yuren,LI Yongjun,LUO Songping,et al.Application of Salvia miltiorrhiza polyphenolate inemergency patients with ischemic myocardial injury[J].,2019,(7):871-874.
点击复制

丹参多酚酸盐在急诊患者缺血性心肌损伤治疗中的应用
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年7期
页码:
871-874
栏目:
临床研究
出版日期:
2019-07-05

文章信息/Info

Title:
Application of Salvia miltiorrhiza polyphenolate inemergency patients with ischemic myocardial injury
文章编号:
DOI:10.3969/j.issn.1000-7369.2019.07.016
作者:
董玉任; 李拥军; 罗松平; 段宝民
河南省开封市中心医院科室急诊科（开封 457000）
Author(s):
DONG Yuren; LI Yongjun; LUO Songping; et al
Department of Emergency,Kaifeng Central Hospital Henan(Kaifeng 457000)
关键词:
丹参多酚酸盐; 急诊; 缺血性心肌损伤; 肌酸激酶; 肌酸激酶同工酶; 乳酸脱氢酶; 丙二醛; 超氧化物歧化酶
Keywords:
Key words Salvia miltiorrhiza polyphenolate; Emergency; Ischemic myocardial injury; Creatine kinase isoenzyme; Creatine kinase; Lactate dehydrogenase; Malondia ldehyde; Super dismutase〖LM〗
分类号:
R542.2
文献标志码:
A
摘要:
摘 要 目的：探讨丹参多酚酸盐在急诊缺血性心肌损伤患者治疗中的应用效果。方法：研究ST段抬高型心肌梗死（STEMI）患者104例，以随机数表法分为对照组与研究组各52例。对照组根据《急性心力衰竭诊断和治疗指南》采取规范药物治疗；在此基础上，研究组应用丹参多酚酸盐进行治疗。评价两组治疗前与治疗14 d时血清丙二醛（MDA）与超氧化物歧化酶（SOD）、心肌酶学指标\[肌酸激酶同工酶（CK-MB）、肌酸激酶（CK）、乳酸脱氢酶（LDH）\]、血液流变学指标（血浆比黏度、全血比黏度、血小板黏附率与红细胞压积）的变化，并统计治疗期间的药物不良反应。结果：治疗后研究组MDA与SOD低于对照组（P＜0.05）。治疗后研究组CK-MB、CK与LDH水平低于对照组（P＜0.05）。治疗后研究组血浆比黏度、全血比黏度、血小板黏附率与红细胞压积低于对照组（P＜0.05）。治疗后研究组血乳酸指标低于对照组（P＜0.05）。对照组与研究组治疗期间各出现头晕1例（1.92%），不良反应发生率对比差异无统计学意义（P＞0.05）。结论：在规范用药治疗的基础上对缺血性心肌损伤患者使用丹参多酚酸盐，能够有效改善心肌酶学与血液流变学指标，抑制心肌损伤，安全可靠 。
Abstract:
Abstract Objective:To investigate the effect of salvianolate in patients with acute ischemic myocardial injury.Methods:104 patients with ST-segment elevation myocardial infarction(STEMI) were divided into control group and research group by random number table method,52 cases in each group.The control group was treated with standard drugs according to the guidelines for diagnosis and treatment of acute heart failure;on this basis,the study group was treated with salvianolate.The changes of Serum malondialdehyde(MDA),Superoxide dismutase(SOD),myocardial enzymatic indexes \[Creatine kinase isoenzyme(CK-MB),Creatine kinase(CK),Lactate dehydrogenase(LDH)\],hemorheological indexes(plasma specific viscosity,whole blood specific viscosity,platelet adhesion rate and hematocrit) were evaluated before and 14 days after treatment in the two groups,and adverse drug reactions during treatment were counted.Results:After treatment,MDA and SOD in the study group were lower than those in the control group(P＜0.05).After treatment,CK-MB,CK and LDH in the study group were lower than those in the control group(P＜0.05).After treatment,the plasma specific viscosity,whole blood specific viscosity,platelet adhesion rate and hematocrit in the study group were lower than those in the control group(P＜0.05).After treatment,the blood lactic acid index in the study group was lower than that in the control group(P＜0.05).During the treatment period,dizziness occurred in 1 case 1.92%in the control group and the control group.There was no significant difference in the incidence of adverse reactions between the two groups(P＞0.05).Conclusion:Salvia miltiorrhiza polyphenolic salts can effectively improve myocardial enzymology and hemorheology indexes,inhibit myocardial injury,and is safe and reliable for patients with ischemic myocardial injury.

参考文献/References:

[1] 韩志龙,王 静.替罗非班、丹参多酚酸盐和曲美他嗪治疗STEMI行PCI术后[J].实用中西医结合临床,2018,18(12):14-16. [2] Walsh M，Whitlock R，Garg AX，et al． Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery(remote IMPACT):a randomized controlled trial[J].CMAJ,2016,188(5):329-336. [3] 魏 娜,贺海波,张长城,等.缺血性心肌损伤及Toll样受体对其调控作用的研究进展[J].中国老年学杂志,2015,35(11):3156-3158. [4] 陈小兰.丹参多酚酸盐联合曲美他嗪胶囊治疗冠心病心绞痛的疗效分析[J].现代实用医学,2018,30(10):1368-1370. [5] 中华医学会心血管病学分会.急性心力衰竭诊断和治疗指南(一)[J].全科医学临床与教育,2010,8(5):484-489. [6] 赵 晶.丹参多酚酸盐治疗82例冠心病不稳定型心绞痛的临床观察[J].内蒙古中医药,2018,37(6):17-18. [7] 陈 晨.丹参多酚酸盐对老年不稳定型心绞痛患者炎症因子及可溶性细胞间黏附分子-1水平的影响[J].中国老年学杂志,2018,38(11):2599-2601. [8] 李 馨,王文斌,曹树军,等.丹参多酚酸盐辅助对不稳定型心绞痛患者TNF-α、hs-CRP、IL-1和心功能的影响[J].临床和实验医学杂志,2018,17(5):499-503. [9] 刘 杲,伊争伟,毛亚妮.经皮冠状动脉支架置入术与尿激酶溶栓治疗急性心肌梗死临床疗效及安全性比 较[J].陕西医学杂志,2018,47(3):347-349，352. [10] 高宏勇,卢 群.瑞替普酶联合还原型谷胱甘肽治疗急性ST段抬高型心肌梗死100例疗效观察[J].陕西医学杂志,2017,46(09):1279-1281. [11] Lanza GA，Stazi A，Villano A，et al． Effect of remote Ischemic preconditioning on platelet activation induced by coronary procedures[J].Am J Cardiol,2016,117(3):359-365. [12] 管笑丹.丹参多酚酸盐对围术期心肌损伤保护临床研究[J].辽宁中医药大学学报,2018,20(3):104-107. [13] 高 洁,盛 婴,金爱萍,等.注射用丹参多酚酸盐对兔主动脉粥样硬化程度的影响[J].陕西医学杂志,2014,43(5):529-530，603. [14] 邱 丹,王 凡,赵 涛.丹参多酚酸盐治疗冠心病心绞痛的疗效及其对血液流变学、氧化应激的影响[J].安徽医药,2018,22(1):147-151. [15] Kleinbongard P，Neuhauser M，Thielmann M，et al． Confounders of cardioprotection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting[J].Cardiology,2016,133(2):128-133. [16] 张金明,陈建军,张艳红.丹参多酚酸盐对缺血再灌注损伤大鼠心肌的保护作用及机制[J].中华实用诊断与治疗杂志,2017,31(11):1055-1058. [17] 刘运平,曹 妍,王慧娟,等.丁苯酞氯化钠联合依达拉奉治疗急性脑梗死患者对血清MDA水平和SOD活力的影响[J].河北医药,2015,37(23):3561-3563. [18] 张广华,李德周,高金贵.全麻复合胸段硬膜外阻滞对心内直视手术MDA、SOD水平的影响[J].河北医药,2009,31(11):1298-1300. [19] 畅 辉,宁小康,韩 克,等.丹参注射液与丹参多酚酸盐注射液对不稳定型心绞痛患者冠状动脉微循环的影响[J].现代生物医学进展,2018,18(12):2294-2297. [20] 张同乐.丹参多酚酸盐联合麝香保心丸治疗冠心病心绞痛疗效观察[J].陕西中医,2017,38(2):176-177. [21] 陈 剑,窦 莉.丹参多酚酸盐治疗心血瘀阻型心绞痛的疗效观察[J].陕西中医,2016,37(11):1458-1459.

相似文献/References:

[1]时晓华.丹参多酚酸盐注射液辅助介入治疗冠心病 及对患者心、肾功能和心肌损伤的影响*[J].陕西中医,2019,(5):568.
　SHI Xiaohua..Effects of salvianolate injection on cardiac function, renal function, myocardial injury in percutaneous coronary intervention postoperative patients with coronary heart disease[J].,2019,(7):568.
[2]孙 哲,杨 默,石宗华.丹参多酚酸盐与丹参酮治疗慢性心力衰竭临床研究[J].陕西中医,2019,(5):591.
　SUN Zhe,YANG Mo,SHI Zonghua..Clinical effect and mechanism of salvianolate and Tanshinone in the treatment of chronic heart failure[J].,2019,(7):591.

更新日期/Last Update: 2019-07-12